410
Views
6
CrossRef citations to date
0
Altmetric
Review

Pathology and systemic therapy of non-clear cell renal cell carcinoma: an overview

, , &
Pages 1273-1286 | Received 07 May 2021, Accepted 20 Jul 2021, Published online: 06 Aug 2021

Keep up to date with the latest research on this topic with citation updates for this article.

Read on this site (1)

Ryo Fujiwara, Susumu Kageyama & Takeshi Yuasa. (2022) Developments in personalized therapy for metastatic renal cell carcinoma. Expert Review of Anticancer Therapy 22:6, pages 647-655.
Read now

Articles from other publishers (5)

Carla Climent, Sandra Soriano, Teresa Bonfill, Natalia Lopez, Marta Rodriguez, Marina Sierra, Pablo Andreu, Monica Fragio, Mireia Busquets, Alicia Carrasco, Ona Cano, Miguel-Angel Seguı́ & Enrique Gallardo. (2023) The role of immunotherapy in non-clear cell renal cell carcinoma. Frontiers in Oncology 13.
Crossref
WEI BAO, QIANGUANG HAN, XIAO GUAN, ZIJIE WANG & MIN GU. (2023) Solute carrier-related signature for assessing prognosis and immunity in patients with clear-cell renal cell carcinoma. Oncology Research 31:2, pages 181-192.
Crossref
Dongshan Chen, Chen Zhang, Yuanwei Zang, Wei Wang & Jiandong Zhang. (2022) Identification of an immune-related gene prognostic index for predicting survival and immunotherapy efficacy in papillary renal cell carcinoma. Frontiers in Genetics 13.
Crossref
Verena M. Prade, Na Sun, Jian Shen, Annette Feuchtinger, Thomas Kunzke, Achim Buck, Peter Schraml, Holger Moch, Kristina Schwamborn, Michael Autenrieth, Jürgen E. Gschwend, Franziska Erlmeier, Arndt Hartmann & Axel Walch. (2022) The synergism of spatial metabolomics and morphometry improves machine learning‐based renal tumour subtype classification. Clinical and Translational Medicine 12:2.
Crossref
Liwei Wei, Yongdi Huang, Zheng Chen, Jinhua Li, Guangyi Huang, Xiaoping Qin, Lihong Cui & Yumin Zhuo. (2022) A Novel Machine Learning Algorithm Combined With Multivariate Analysis for the Prognosis of Renal Collecting Duct Carcinoma. Frontiers in Oncology 11.
Crossref

Reprints and Corporate Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

To request a reprint or corporate permissions for this article, please click on the relevant link below:

Academic Permissions

Please note: Selecting permissions does not provide access to the full text of the article, please see our help page How do I view content?

Obtain permissions instantly via Rightslink by clicking on the button below:

If you are unable to obtain permissions via Rightslink, please complete and submit this Permissions form. For more information, please visit our Permissions help page.